These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34785348)

  • 1. Role of moesin in the effect of glucagon-like peptide-1 on advanced glycation end products-induced endothelial barrier dysfunction.
    Liu Y; Chen Z; Liu L; Tang H; Zhu H; Tang S
    Cell Signal; 2022 Feb; 90():110193. PubMed ID: 34785348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-1 attenuates endothelial barrier injury in diabetes via cAMP/PKA mediated down-regulation of MLC phosphorylation.
    Tang ST; Tang HQ; Su H; Wang Y; Zhou Q; Zhang Q; Wang Y; Zhu HQ
    Biomed Pharmacother; 2019 May; 113():108667. PubMed ID: 30852419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability.
    Guo X; Wang L; Chen B; Li Q; Wang J; Zhao M; Wu W; Zhu P; Huang X; Huang Q
    Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H238-46. PubMed ID: 19395553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response.
    Wang J; Liu H; Chen B; Li Q; Huang X; Wang L; Guo X; Huang Q
    Cardiovasc Diabetol; 2012 Jan; 11():7. PubMed ID: 22251897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products induce moesin phosphorylation in murine brain endothelium.
    Li Q; Liu H; Du J; Chen B; Li Q; Guo X; Huang X; Huang Q
    Brain Res; 2011 Feb; 1373():1-10. PubMed ID: 21167822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products induce immature angiogenesis in in vivo and ex vivo mouse models.
    Chen L; Cui Y; Li B; Weng J; Wang W; Zhang S; Huang X; Guo X; Huang Q
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H519-H533. PubMed ID: 31922896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products induce moesin phosphorylation in murine retinal endothelium.
    Wang L; Li Q; Du J; Chen B; Li Q; Huang X; Guo X; Huang Q
    Acta Diabetol; 2012 Feb; 49(1):47-55. PubMed ID: 21327982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of moesin, Src, and ROS in advanced glycation end product-induced vascular endothelial dysfunction.
    Zhang WJ; Li PX; Guo XH; Huang QB
    Microcirculation; 2017 Apr; 24(3):. PubMed ID: 28129474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Moesin Phosphorylation in Retinal Pericyte Migration and Detachment Induced by Advanced Glycation Endproducts.
    Zhang SS; Hu JQ; Liu XH; Chen LX; Chen H; Guo XH; Huang QB
    Front Endocrinol (Lausanne); 2020; 11():603450. PubMed ID: 33312163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor κB signaling pathways.
    Tang ST; Zhang Q; Tang HQ; Wang CJ; Su H; Zhou Q; Wei W; Zhu HQ; Wang Y
    Endocrine; 2016 Jul; 53(1):107-16. PubMed ID: 26758998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Moesin in Advanced Glycation End Products-Induced Angiogenesis of Human Umbilical Vein Endothelial Cells.
    Wang Q; Fan A; Yuan Y; Chen L; Guo X; Huang X; Huang Q
    Sci Rep; 2016 Mar; 6():22749. PubMed ID: 26956714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement.
    Adyshev DM; Moldobaeva NK; Elangovan VR; Garcia JG; Dudek SM
    Cell Signal; 2011 Dec; 23(12):2086-96. PubMed ID: 21864676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liraglutide improved the cognitive function of diabetic mice via the receptor of advanced glycation end products down-regulation.
    Zhang H; Chu Y; Zheng H; Wang J; Song B; Sun Y
    Aging (Albany NY); 2020 Nov; 13(1):525-536. PubMed ID: 33298623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1 receptor regulates receptor of advanced glycation end products in high glucose-treated rat mesangial cells.
    Chang JT; Liang YJ; Leu JG
    J Chin Med Assoc; 2023 Jan; 86(1):39-46. PubMed ID: 36599141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of p38MAPK/eNOS signaling pathway in the inhibition of AGEs-induced apoptosis of human umbilical vein endothelial cells by glucagon-like peptide-1].
    Zeng H; Huang Z; Zhang Y; Sun H
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):116-9, 139. PubMed ID: 26806750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
    Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
    Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs)-induced apoptosis.
    Zhan Y; Sun HL; Chen H; Zhang H; Sun J; Zhang Z; Cai DH
    Med Sci Monit; 2012 Jul; 18(7):BR286-91. PubMed ID: 22739729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezrin, radixin, and moesin are phosphorylated in response to 2-methoxyestradiol and modulate endothelial hyperpermeability.
    Bogatcheva NV; Zemskova MA; Gorshkov BA; Kim KM; Daglis GA; Poirier C; Verin AD
    Am J Respir Cell Mol Biol; 2011 Dec; 45(6):1185-94. PubMed ID: 21659656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation.
    Barale C; Buracco S; Cavalot F; Frascaroli C; Guerrasio A; Russo I
    Thromb Haemost; 2017 Jun; 117(6):1115-1128. PubMed ID: 28405672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLP-1 inhibits PKCβ2 phosphorylation to improve the osteogenic differentiation potential of hPDLSCs in the AGE microenvironment.
    Wang Z; Wang X; Zhang L; Wang B; Xu B; Zhang J
    J Diabetes Complications; 2020 Mar; 34(3):107495. PubMed ID: 31785994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.